SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

On November 2021, 4chan created a female alternative to Wojak/PePe called “GleGle.”

glegle

GLEGLE is trending as retail investors rally behind the low-market-cap meme coin, focusing on aggressive community-led buying efforts to drive valuation higher. While many participants view it as a high-risk speculative play, others remain heavily engaged in social media campaigns to maintain momentum and reach higher market cap milestones.

Crane Harbor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 2, 2025 and is headquartered in Philadelphia, PA.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies has generated significant attention following its debut as a publicly traded company, with retail investors actively debating market volatility, potential share manipulation, and the platform's role in the future of quantum computing for AI. Discussions are currently dominated by concerns over broker trading restrictions and the firm's long-term potential as a leader in photonic quantum hardware.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors focus on upcoming Phase 3 trial data for sonelokimab, which is being positioned by the community as a potential best-in-class treatment for hidradenitis suppurativa. Market participants are closely watching for clinical outcomes and potential M&A activity following recent analyst upgrades and continued institutional accumulation.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to a massive earnings beat and the announcement of a strategic acquisition of SkyWater Technology, which has triggered a significant short squeeze. While bulls celebrate the company's revenue growth and aggressive expansion in the quantum sector, skeptics are actively highlighting risks related to potential share dilution and concerns over the company's long-term path to profitability.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing increased scrutiny from the community following news of a second subscription price increase within a year, with many investors debating whether this demonstrates strong pricing power or risks significant subscriber churn. While analysts generally maintain a bullish outlook citing revenue growth potential, traders are actively discussing the stock's volatility and its ability to maintain momentum amidst broader market uncertainty.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently a focal point for investors as the community debates the impact of recent convertible note offerings, institutional buying patterns, and high short interest against a backdrop of potential acquisition rumors. Discussions are heavily focused on the clinical progress of their gene-editing pipeline, with sentiment split between long-term confidence in their breakthrough technology and frustration over the stock's stagnant price action and management's capital allocation strategies.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors digest news of CPU price hikes alongside aggressive AI demand, fueling a strong technical breakout that has shifted sentiment from recent consolidation to bullish momentum. While some community members remain cautious about geopolitical risks and potential profit-taking, the broader discussion highlights strong institutional interest and long-term confidence in the company's competitive position in the AI hardware space.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly (LLY) is trending as the market processes a competitive trial readout comparing its oral drug orforglipron to Novo Nordisk's oral semaglutide, with investors debating the trade-off between higher efficacy and greater side-effect-related discontinuation rates. Concurrently, sentiment is pressured by an HSBC downgrade citing valuation concerns, while community discussion remains focused on the long-term impact of regulatory scrutiny regarding compounded GLP-1 alternatives and the stock's positioning ahead of major FDA milestones.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is currently navigating intense volatility as the broader crypto market faces significant downward pressure from geopolitical tensions in the Middle East and macroeconomic concerns. The community is actively debating whether current price levels represent a bottoming opportunity or a precursor to further losses, while institutional activity and broader market correlations remain central to investor sentiment.

The Shrimp Army

SHRIMPS is trending as part of a wider wave of marine-themed meme coins that investors are actively rotating through. While the community is hyped about potential price breakouts and the ability to eliminate zeros, many participants are cautioning others about the extreme volatility and high risk of quick pullbacks common in this sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exchange Traded Concepts LLC Increases Position in Kinder Morgan, Inc. $KMI

Exchange Traded Concepts LLC lifted its holdings in Kinder Morgan, Inc. (NYSE:KMI - Free Report) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the...

Fort Washington Investment Advisors Inc. OH Increases Stock Holdings in Kinder Morgan, Inc. $KMI

Fort Washington Investment Advisors Inc. OH increased its stake in shares of Kinder Morgan, Inc. (NYSE:KMI - Free Report) by 5.5% in the 4th quarter, according to its most recent Form 13F filing with...

Scotiabank Forecasts Strong Price Appreciation for Kinder Morgan (NYSE:KMI) Stock

Scotiabank boosted their price target on shares of Kinder Morgan from $31.00 to $32.00 and gave the stock a "sector perform" rating in a research note on Thursday...

CVA Family Office LLC Sells 38,719 Shares of Kinder Morgan, Inc. $KMI

CVA Family Office LLC reduced its stake in Kinder Morgan, Inc. (NYSE:KMI - Free Report) by 36.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange...

Kinder Morgan (NYSE:KMI) Hits New 1-Year High Following Analyst Upgrade

Kinder Morgan (NYSE:KMI) Reaches New 12-Month High Following Analyst Upgrade...

Kinder Morgan, Inc. (KMI) is Attracting Investor Attention: Here is What You Should Know  

Recently, Zacks.com users have been paying close attention to Kinder Morgan (KMI). This makes it worthwhile to examine what the stock has in store.

Wealth Enhancement Advisory Services LLC Buys 350,348 Shares of Kinder Morgan, Inc. $KMI

Wealth Enhancement Advisory Services LLC increased its stake in Kinder Morgan, Inc. (NYSE:KMI - Free Report) by 44.6% in the 4th quarter, according to the company in its most recent disclosure with...

Phillips 66 and Kinder Morgan, Inc. Announce Extension of Second Open Season for Remaining Western Gateway Capacity

Phillips 66 (NYSE: PSX) and Kinder Morgan, Inc. (NYSE: KMI) today announced an extension of the second open season for the Western Gateway Pipeline (Western Gateway), a newly proposed refined...

US Capital Advisors Forecasts Kinder Morgan FY2028 Earnings

Kinder Morgan, Inc. (NYSE:KMI - Free Report) - Stock analysts at US Capital Advisors issued their FY2028 earnings per share estimates for Kinder Morgan in a note issued to investors on Monday, March...

SG Americas Securities LLC Purchases 1,790,475 Shares of Kinder Morgan, Inc. $KMI

SG Americas Securities LLC increased its position in Kinder Morgan, Inc. (NYSE:KMI - Free Report) by 554.8% in the 4th quarter, according to its most recent disclosure with the Securities and...

Kinder Morgan, Inc. engages in providing pipeline transportation of natural gas services. It operates through the following business segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO2. The Natural Gas Pipelines segment operates major interstate and intrastate natural gas pipelines and storage systems. The Products Pipelines segment is involved in the operation of refined petroleum products, crude oil, and condensate pipelines. The Terminals segment includes the operation of liquids and bulk terminal facilities that store and handle various commodities. The CO2 segment produces, transports, and markets to oil fields that use CO2 as a flooding medium to increase recovery and production of crude oil from mature oil fields. The company was founded by Richard D. Kinder and William V. Morgan in February 1997 and is headquartered in Houston, TX.

Kinder Morgan Inc - Ordinary Shares - Class P

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Current Price	$34.03
Prev Close	$34.07
Open	$34.00
Dividend Yield	4.24%
50-Day Moving Average	$31.87
Beta	0.56
Avg. Volume	13.52M
PE Ratio	24.90

52-Week High	$34.73
52-Week Low	$23.94
Market Capitalization	$75.71B
EPS (Annual)	$1.37
Price to Book	2.43
Revenue Per Employee	$1.52M

KMI
Kinder Morgan Inc - Ordinary Shares - Class P

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KMI News

KMIKinder Morgan Inc - Ordinary Shares - Class P